grants_govRFA-AI-27-004
Open
Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)
- Response deadline
- Sep 24, 2026 Closed
- Date posted
- Jun 29, 2026
- Source
- Open notice
Description
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis with emphasis on chronic skin inflammation and the defense mechanisms of the skin.
Classifications
- NAICS93.855
Documents (1)
- RFA-AI-27-004-Full-Announcement.htmltext/html;charset=UTF-8194 KBNot yet available
Contacts
Similar contracts
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)Due Feb 11, 2027
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)Due Nov 10, 2026
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)Due Nov 10, 2026
- Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)Due Jul 7, 2028
- Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed)Due Jul 1, 2028
- NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)Due Jul 5, 2029